Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-Pen Mini Dose-Ranging Study in T1DM
NCT02081014Phase 2Completed
- Sponsor
- Xeris Biopharma Holdings, Inc.
- Start
- Mar 2014
- Primary completion
- Nov 2014
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of glucagon in hypoglycemia, sponsored by Xeris Biopharma Holdings, Inc.. Started Mar 2014; status: completed.
02
Drugs
glucagon
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT02081014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02081014.